moclobemide has been researched along with Ischemia in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dominguez, J | 2 |
| Troncoso, P | 2 |
| Martinez, L | 2 |
| Zambrano, N | 1 |
2 other studies available for moclobemide and Ischemia
| Article | Year |
|---|---|
Monoamine oxidase inhibition prevents ischemia reperfusion damage in rat kidneys.
Topics: Animals; Benzamides; Creatinine; Dose-Response Relationship, Drug; Ischemia; Kidney; Kidney Function | 1995 |
Oxidative damage markers in a renal ischemic-reperfusion model: the protective effect of monoamine oxidase inhibition.
Topics: Animals; Benzamides; Biomarkers; Creatinine; Glutathione; Ischemia; Kidney; Lipid Peroxidation; Male | 1995 |